The game is afoot in the obesity space as GLP-1 rivals Eli Lilly and Novo Nordisk take their showdown to a new level. Lilly ...

Three Motley Fool contributors think they've found no-brainer healthcare stocks to buy in May. Here's why they picked Eli ...

This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...

Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

After taking part in a landmark case against the manufacturers of the synthetic hormone DES, she represented many other ...

Our writer explains why he just added to a big loser to his Stocks and Shares ISA portfolio, despite it going against one of ...

Fawn Weaver, co-founder of Uncle Nearest Whiskey, encouraged FAMU graduates to defy limitations in her commencement speech.

The FDA accepted Novo Nordisk's NDA for an oral formulation of Wegovy. The agency is expected to release its verdict on the ...

Plus, the National Academy of Sciences received $20 million, Agnes Scott College got $15 million, and three other ...

These three stocks could potentially help investors create a stable – and growing – stream of passive income in the years ...

The pharma industry’s reputation dropped slightly again among patient groups, largely due to drug pricing issues.

The first nonstop Aer Lingus flight from Dublin, Ireland landed Saturday night, but the long-term impact is just starting to take off.